株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

抗菌薬の世界市場:産業分析、市場規模、シェア、成長、動向、予測(2017年〜 2025年)

Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

発行 Transparency Market Research 商品コード 297657
出版日 ページ情報 英文 189 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.88円で換算しております。
Back to Top
抗菌薬の世界市場:産業分析、市場規模、シェア、成長、動向、予測(2017年〜 2025年) Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
出版日: 2017年12月14日 ページ情報: 英文 189 Pages
概要

世界の抗菌薬市場は、薬物クラス別に、Bラクタム、キノロン、マクロライド、テトラサイクリン、アミノグリコシド、スルホンアミド、フェニコールなどに分類されています。流通チャネル別では病院薬局、ドラッグストア、小売薬局、オンライン販売に区分されており、その中でもドラッグストアは2016年に最大の市場シェアを握り、2017年から2025年の予測期間においては大幅に成長するものと予測されています。

当レポートでは、抗菌薬の世界市場を調査し、市場の概要、薬物クラス・投与経路・流通チャネル・地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 報告範囲と市場セグメンテーション
  • 研究のハイライト
  • 前提と頭字語の使用

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場の概要

  • 製品の概要
  • 主要産業の発展
  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会の分析
    • ファイブフォース分析
    • バリューチェーン分析と供給需要シナリオ
    • 市場の見通し
    • パイプライン分析

第5章 世界の抗菌薬市場:薬剤クラス別

  • 主な所見
  • 定義
  • イントロダクション
  • 市場シェアの分析:薬剤クラス別
  • 市場分析:薬剤クラス別
    • B-ラクタム
    • キノロン類
    • マクロライド
    • テトラサイクリン
    • アミノグリコシド
    • スルホンアミド
    • フェニコール
    • その他
  • 市場魅力度の分析
  • 市場予測
  • 主要動向

第6章 世界の抗菌薬市場:投与経路別

  • 主な所見
  • 定義
  • イントロダクション
  • 市場シェアの分析:投与経路別
  • 市場分析:薬剤クラス別
    • 腸内投与
    • 静脈投与
    • その他
  • 市場魅力度の分析
  • 主要動向

第7章 世界の抗菌薬市場:流通チャネル別

  • 主な所見
  • 定義
  • イントロダクション
  • 市場シェアの分析:流通チャネル別
  • 市場分析:流通チャネル別
    • 病院薬局
    • ドラッグストア・小売薬局
    • オンライン
  • 市場魅力度の分析
  • 市場予測:流通経路別
  • 主要動向

第8章 世界の抗菌薬市場:地域別

  • 主な所見
  • イントロダクション
  • 市場規模の分析
  • 市場魅力度の分析
  • 市場予測

第9章 北米

第10章 欧州

第11章 アジア太平洋

第12章 ラテンアメリカ

第13章 中東・アフリカ

第14章 競争の景観

  • 売上上位の抗菌薬
  • 競合マトリクス
  • 企業プロファイル
    • Bayer AG
    • Pfizer Inc.
    • Sanofi
    • GlaxoSmithKline plc
    • Merck & Co., Inc
    • AstraZeneca
    • Johnson and Johnson
    • Bristol-Myers Squibb Company
    • Novartis AG
    • Allergen Plc.
目次

Title:
Antibacterial Drugs Market (Drug Class - B - lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Sulfonamide, and Phenicols; Routes of Administration - Enteral and Parenteral; Distribution Channel - Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.

Global Antibacterial Drugs Market: Overview

This report provides in-depth region wise and country wise analysis of the antibacterial drugs market. Stakeholders of this report include manufacturers of antibacterial drugs, raw material suppliers, researchers and new players planning to enter the market.

The report provides qualitative and quantitative analysis of the global antibacterial drugs market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes market share held by companies, market size, and forecast for the global antibacterial drugs market in major countries globally such as the U.S., Canada, Germany, France, United Kingdom, Japan, China,, India, Brazil, Mexico, South Africa GCC countries and others. Market revenue is provided in terms of US$ Mn from 2015 to 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 for all the segments, considering 2016 as the base year. The executive summary of the report provides a snapshot of the antibacterial drugs with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors.

Global Antibacterial Drugs Market: Scope of the Study

The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global antibacterial drugs market. These factors would aid the stakeholders in establishing a strong foothold in the global antibacterial drugs market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the antibacterial drugs. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.

Global Antibacterial Drugs Market: Key Segments

Based on drug class, the global antibacterial drugs market is classified into B - lactams, quinolones, macrolides, tetracycline, aminoglycoside, sulfonamide, phenicols, and others. In terms of routes of administration, the global antibacterial drugs market has been segmented into enteral, parenteral and others. Likewise, the global antibacterial drugs market has been further segmented into hospital pharmacies, drug stores and retail pharmacies and online sales, in terms of distribution channel. The retail stores and drug stores segment is anticipated to experience the largest market share in 2016 and this segment will grow by a significant rate during the forecast period.

Global Antibacterial Drugs Market: Regional Outlook

Geographically, the antibacterial drugs market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Japan, China, India, Brazil, Mexico, and South Africa and others have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the antibacterial drugs market in various regions has been provided in this section.

Global Antibacterial Drugs Market: Competitive Outlook

This report also includes various ups and downs about particular country or geography that has impacted the overall market globally. The report provides a detailed outline/blueprint of the antibacterial drugs market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. Prominent key players are Bayer AG, Pfizer Inc., Sanofi, GlaxoSmithKline Plc. (GSK), Merck & Co., Inc., AstraZeneca, Johnson and Johnson, Bristol Myers Squibb Company, Novartis AG, and Allergen plc

Global antibacterial drugs market is segmented as given below:

  • Global Antibacterial Drugs Market, by Drug Class
  • B - lactams
  • Quinolones
  • Macrolides
  • Tetracycline
  • Aminoglycoside
  • Sulfonamide
  • Phenicols
  • Others
  • Global Antibacterial Drugs Market, by Routes of Administration
  • Enteral,
  • Parenteral
  • Others
  • Global Antibacterial Drugs Market, by Distribution Channel
  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Sales
  • Global Antibacterial Drugs Market, by Geography
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Rest of Europe
  • Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC
  • Latin America (LATAM)
  • Brazil
  • Mexico
  • Rest of LATAM
  • Middle East & Africa (MEA)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights
  • 1.3. Assumptions and Acronyms Used

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Market Overview

  • 4.1. Product Overview
  • 4.2. Key Industry Developments
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunity Analysis
    • 4.3.4. Porter's Five Forces Representation
    • 4.3.5. Antibacterial Drugs Market- Value Chain Analysis & Supply-Demand Scenario
    • 4.3.6. Antibacterial Drugs Market Outlook
    • 4.3.7. Anti-Bacterial Drugs Pipeline Analysis

Chapter 5. Global Antibacterial Drugs Market Analysis, by Drug Class, 2015 - 2025

  • 5.1. Key Findings
  • 5.2. Definition
  • 5.3. Introduction
  • 5.4. Global Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • 5.5. Global Antibacterial Drugs Market Analysis, by Drug Class
    • 5.5.1. B-lactam
    • 5.5.2. Quinolones
    • 5.5.3. Macrolides
    • 5.5.4. Tetracycline
    • 5.5.5. Aminoglycoside
    • 5.5.6. Sulfonamide
    • 5.5.7. Phenicols
    • 5.5.8. Others
  • 5.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Drug Class
  • 5.7. Global Antibacterial Drugs Market Forecast, by Drug Class
  • 5.8. Key Trends

Chapter 6. Global Antibacterial Drugs Market Analysis, by Routes of Administration

  • 6.1. Key Findings
  • 6.2. Definitions
  • 6.3. Introduction
  • 6.4. Global Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • 6.5. Global Antibacterial Drugs Market Analysis, by Routes of Administration
    • 6.5.1. Enteral
    • 6.5.2. Parenteral
    • 6.5.3. Others
  • 6.6. Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration
  • 6.7. Global Antibacterial Drugs Market Forecast, by Routes of Administration

Chapter 7. Global Antibacterial Drugs Market Analysis, by Channels of Distribution

  • 7.1. Key Findings
  • 7.2. Definitions
  • 7.3. Introduction
  • 7.4. Global Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • 7.5. Global Antibacterial Drugs Market Analysis, by Channels of Distribution
    • 7.5.1. Hospital Pharmacies
    • 7.5.2. Drug Stores & Retail Pharmacies
    • 7.5.3. Online Sales
  • 7.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution
  • 7.7. Global Antibacterial Drugs Market Forecast, by Channels of Distribution
  • 7.8. Key Trends

Chapter 8. Global Antibacterial Drugs Market Analysis, by Region

  • 8.1. Key Findings
  • 8.2. Introduction
  • 8.3. Global Antibacterial Drugs Market Value Share Analysis, by Region, 2016 and 2025
  • 8.4. Global Antibacterial Drugs Market Attractiveness Analysis, by Region, 2016
  • 8.5. Global Antibacterial Drugs Market Forecast, by Region, 2015-2025

Chapter 9. North America Antibacterial Drugs Market Analysis

  • 9.1. North America Antibacterial Drugs Market Overview
  • 9.2. North America Antibacterial Drugs Market Forecast, Country wise, 2015-2025
  • 9.3. North America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • 9.4. North America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • 9.5. North America Antibacterial Drugs Market Forecast, by Drug Class, 2015-2025
  • 9.6. North America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • 9.7. North America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • 9.8. North America Antibacterial Drugs Market Forecast, by Routes of Administration, 2015-2025
  • 9.9. North America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • 9.10. North America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
  • 9.11. North America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015-2025
  • 9.12. Key Trends

Chapter 10. Europe Antibacterial Drugs Market Analysis

  • 10.1. Europe Antibacterial Drugs Market Overview
  • 10.2. Europe Antibacterial Drugs Market Forecast, Country wise, 2015-2025
  • 10.3. Europe Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • 10.4. Europe Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • 10.5. Europe Antibacterial Drugs Market Forecast, by Drug Class, 2015-2025
  • 10.6. Europe Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • 10.7. Europe Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • 10.8. Europe Antibacterial Drugs Market Forecast, by Routes of Administration, 2015-2025
  • 10.9. Europe Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • 10.10. Europe Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
  • 10.11. Europe Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015-2025
  • 10.12. Key Trends

Chapter 11. Asia Pacific Antibacterial Drugs Market Analysis

  • 11.1. Asia Pacific Antibacterial Drugs Market Overview
  • 11.2. Asia Pacific Antibacterial Drugs Market Forecast, Country wise, 2015-2025
  • 11.3. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • 11.4. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • 11.5. Asia Pacific Antibacterial Drugs Market Forecast, by Drug Class, 2015-2025
  • 11.6. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • 11.7. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • 11.8. Asia Pacific Antibacterial Drugs Market Forecast, by Routes of Administration, 2015-2025
  • 11.9. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • 11.10. Pacific Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
  • 11.11. Asia Pacific Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015-2025
  • 11.12. Key Trends

Chapter 12. Latin America Antibacterial Drugs Market Analysis

  • 12.1. Latin America Antibacterial Drugs Market Overview
  • 12.2. Latin America Antibacterial Drugs Market Forecast, Country wise, 2015-2025
  • 12.3. Latin America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • 12.4. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • 12.5. Latin America Antibacterial Drugs Market Forecast, by Drug Class, 2015-2025
  • 12.6. Latin America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • 12.7. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • 12.8. Latin America Antibacterial Drugs Market Forecast, by Routes of Administration, 2015-2025
  • 12.9. Latin America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • 12.10. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
  • 12.11. Latin America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015-2025
  • 12.12. Key Trends

Chapter 13. Middle East & Africa Antibacterial Drugs Market Analysis

  • 13.1. Middle East & Africa Antibacterial Drugs Market Overview
  • 13.2. Middle East & Africa Antibacterial Drugs Market Forecast, Country wise, 2015-2025
  • 13.3. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • 13.4. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • 13.5. Middle East & Africa Antibacterial Drugs Market Forecast, by Drug Class, 2015-2025
  • 13.6. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • 13.7. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • 13.8. Middle East & Africa Antibacterial Drugs Market Forecast, by Routes of Administration, 2015-2025
  • 13.9. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • 13.10. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
  • 13.11. Middle East & Africa Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015-2025
  • 13.12. Key Trends

Chapter 14. Competition Landscape

  • 14.1. Leading Antibacterial Drugs Sales Analysis, 2014 - 2016
  • 14.2. Competition Matrix
  • 14.3. Company Profiles
    • 14.3.1. Bayer AG
      • 14.3.1.1. Company Description
      • 14.3.1.2. Business Overview
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Strategic Overview
    • 14.3.2. Pfizer Inc.
      • 14.3.2.1. Company Description
      • 14.3.2.2. Business Overview
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Strategic Overview
    • 14.3.3. Sanofi
      • 14.3.3.1. Company Description
      • 14.3.3.2. Business Overview
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Strategic Overview
    • 14.3.4. GlaxoSmithKline plc
      • 14.3.4.1. Company Description
      • 14.3.4.2. Business Overview
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Strategic Overview
    • 14.3.5. Merck & Co., Inc
      • 14.3.5.1. Company Description
      • 14.3.5.2. Business Overview
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Strategic Overview
    • 14.3.6. AstraZeneca
      • 14.3.6.1. Company Description
      • 14.3.6.2. Business Overview
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Strategic Overview
    • 14.3.7. Johnson and Johnson
      • 14.3.7.1. Company Description
      • 14.3.7.2. Business Overview
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Strategic Overview
    • 14.3.8. Bristol-Myers Squibb Company
      • 14.3.8.1. Company Description
      • 14.3.8.2. Business Overview
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Strategic Overview
    • 14.3.9. Novartis AG
      • 14.3.9.1. Company Description
      • 14.3.9.2. Business Overview
      • 14.3.9.3. SWOT Analysis
      • 14.3.9.4. Strategic Overview
    • 14.3.10. Allergen Plc.
      • 14.3.10.1. Company Description
      • 14.3.10.2. Business Overview
      • 14.3.10.3. SWOT Analysis
      • 14.3.10.4. Strategic Overview

List of Tables

  • Table 01: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 02: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015-2025
  • Table 03: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015-2025
  • Table 04: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 05: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2015-2025
  • Table 06: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 07: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015-2025
  • Table 08: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distributions, 2015-2025
  • Table 09: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2015-2025
  • Table 10: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 11: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015-2025
  • Table 12: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015-2025
  • Table 13: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2015-2025
  • Table 14: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 15: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015-2025
  • Table 16: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015-2025
  • Table 17: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Country Wise, 2015-2025
  • Table 18: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 19: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015-2025
  • Table 20: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015-2025
  • Table 21: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, by Country Wise, 2015-2025
  • Table 22: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 23: MEA Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015-2025
  • Table 24: MEA Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015-2025

List of Figures

  • Figure 01: Global Antibacterial Drugs Market Size ($ Mn) and Distribution by Geography, 2017 and 2025
  • Figure 02: Global Antibacterial Drugs Market Revenue (US$ Mn) and top 3 trends
  • Figure 03: Global Antibacterial Drugs Market, by Channels of Distribution, Revenue (US$ Mn) and Market Share
  • Figure 04: Market Value Share By Drug Class (2017) Revenue (US$ Mn)
  • Figure 05: Market Value Share By Region (2017) Revenue (US$ Mn)
  • Figure 06: Antibacterial Drugs in Clinical Trials
  • Figure 07: Anti-bacterial Drugs by Indication
  • Figure 08: Anti-bacterial Drugs by class
  • Figure 09: Global Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • Figure 10: Global B-lactam Market Revenue (US$ Mn) and Y-o-Y Growth (%), by B-lactam, 2015-2025
  • Figure 11: Global Quinolones Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 12: Global Macrolides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 13: Global Tetracyclines Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 14: Global Aminoglycosides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 15: Global Sulfonamides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 16: Global Phenicols Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 17: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 18: Global Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • Figure 19: Global Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • Figure 20: Global Enteral Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 21: Global Parenteral Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 22: Global Others routes of administration Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 23: Global Antibacterial Drugs Market Attractiveness Analysis, by Routes od Administration, 2016
  • Figure 24: Global Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • Figure 25: Global Hospital Pharmacies Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 26: Global Drug Stores & Retail Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 27: Global Online Sales Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025
  • Figure 28: Global Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
  • Figure 29: Global Antibacterial Drugs Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 30: Global Antibacterial Drugs Market Attractiveness Analysis, by Region, 2016
  • Figure 31: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 32: North America Antibacterial Drugs Market Y-o-Y Growth Projections, 2015-2025
  • Figure 33: North America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • Figure 34: North America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • Figure 35: North America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • Figure 36: North America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • Figure 37: North America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • Figure 38: North America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
  • Figure 39: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 40: Europe Antibacterial Drugs Market Y-o-Y Growth Projections, 2015-2025
  • Figure 41: Europe Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • Figure 42: Europe Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • Figure 43: Europe Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • Figure 44: Europe Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • Figure 45: Europe Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • Figure 46: Europe Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2016
  • Figure 47: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 48: Asia Pacific Antibacterial Drugs Market Y-o-Y Growth Projections, 2017-2025
  • Figure 49: Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • Figure 50: Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • Figure 51: Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • Figure 52: Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • Figure 53: Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • Figure 54: Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2016
  • Figure 55: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 56: Latin America Antibacterial Drugs Market, Y-o-Y Growth Projection, 2015-2025
  • Figure 57: Latin America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • Figure 58: Latin America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • Figure 59: Latin America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • Figure 60: Latin America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • Figure 61: Latin America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • Figure 62: Latin America Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2016
  • Figure 63: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 64: Middle East & Africa Antibacterial Drugs Market Y-o-Y Growth Projections, 2015-2025
  • Figure 65: Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • Figure 66: Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • Figure 67: MEA Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • Figure 68: MEA Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • Figure 69: MEA Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • Figure 70: MEA Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2016
  • Figure 71: Leading Antibacterial Drugs Sales Analysis, 2014 - 2016
  • Figure 72: Bayer AG, Breakdown of Net Sales, by Region, 2016
  • Figure 73: Bayer AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013-2016
  • Figure 74: Pfizer, Breakdown of Net Sales, by Region, 2016
  • Figure 75: Pfizer, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2016
  • Figure 76: Sanofi, Breakdown of Net Sales, by Region, 2016
  • Figure 77: Sanofi, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2016
  • Figure 78: GlaxoSmithKline, Breakdown of Net Sales, by Region, 2016
  • Figure 79: GlaxoSmithKline, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2016
  • Figure 80: Merck & Co., Breakdown of Net Sales, by Region, 2016
  • Figure 81: Merck & Co., Revenue (US$ Mn) & Y-o-Y Growth (%), 2013-2016
  • Figure 82: AstraZeneca, Breakdown of Net Sales, by Region, 2016
  • Figure 83: AstraZeneca, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2016
  • Figure 84: Johnson & Johnson, Breakdown of Net Sales, by Region, 2016
  • Figure 85: Johnson & Johnson, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2016
  • Figure 86: Bristol-Myers Squibb Company, Breakdown of Net Sales, by Region (2016)
  • Figure 87: Bristol-Myers Squibb Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2016
  • Figure 88: Novartis AG, Breakdown of Net Sales, by Region, 2016
  • Figure 89: Novartis AG, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2016
  • Figure 90: Allergen, Breakdown of Net Sales (%), by Segments (2016)
  • Figure 91: Allergen, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2016
Back to Top